首页> 外国专利> A controlled release Tablet comprising betahistine and a process for the preparation of the tablet

A controlled release Tablet comprising betahistine and a process for the preparation of the tablet

机译:包含倍他司汀的控释片剂及其制备方法

摘要

A controlled release Tablet comprising an active ingredient which is a Salt of the same betahistine or acceptable for pharmaceutical use.Incorporated in at least a Fatty compound; at least a Hydrophilic Polymer able to absorb Water and suitable excipients.Betahistine is an active Vasodilator used for oral administration in the treatment of vertigo.The preparation of a Pharmaceutical Form with a suitable Release Profile of betahistine would reduce the amount of daily Administrations only.While maintaining a constant concentration of the active ingredient within the therapeutic dose Range.A process for the preparation of Controlled Release Tablets comprising the steps of: (a) to incorporate the active ingredient of it,In at least a Fatty Compound by Melt granulation; (b) The Step to mix the Granules with at least a compound Hydrophilic excipients and appropriate; (c) subjecting the mixture of compressionL STEP (b).
机译:控释片剂,其包含活性成分,该活性成分为相同的β组氨酸的盐或药学上可接受的盐。至少可以吸收水的亲水性聚合物和合适的赋形剂。倍他司汀是一种活性的血管舒张剂,用于口服治疗眩晕。制备具有合适的倍他司汀释放特性的药物形式只会减少每天的给药量。制备控释片剂的方法包括以下步骤:(a)通过熔融制粒将其活性成分掺入至少一种脂肪化合物中;同时将活性成分的浓度保持在治疗剂量范围内。 (b)将颗粒与至少一种复合亲水性赋形剂和适当的物质混合的步骤; (c)对混合物进行压缩L步骤(b)。

著录项

  • 公开/公告号AR029154A1

    专利类型

  • 公开/公告日2003-06-18

    原文格式PDF

  • 申请/专利权人 FARMACEUTICI FORMENTI S.P.A.;

    申请/专利号AR2000P100974

  • 发明设计人

    申请日2000-03-03

  • 分类号A61K9/20;A61K9/22;A61K31/4402;A61P9/08;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号